SHOPPING: Shoppers are turning to Calocrub Supplements for faster, more effective weight loss claiming it's better than ...

Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later ...

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

Columbia scientists have found specialized neurons in the brains of mice that order the animals to stop eating. The findings ...

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.

Redmond, founder and CEO of Dr. Stephanie’s Supplements, showcased her products, which she described as the latest innovations in supplement options for hormone and metabolic health, including a ...

The international formula was designed to deliver all the benefits of the US formula while meeting regulatory requirements ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation ...